Glenn Saldanha is a pharmaceutical executive associated with the transformation of Glenmark into an internationally active pharmaceutical organization. His leadership has emphasized research, specialty medicines, global market development and the evolution of the company's innovation agenda. With experience in international business and pharmaceutical strategy, he has helped expand Glenmark's footprint beyond India while maintaining significant capabilities in branded generics and therapeutic research.
